These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2658394)

  • 21. [Therapy effects of fenofibrate on alcoholic fatty liver and drug-induced fatty liver in rats].
    Yan M; Meng FL; Lu RJ; Jia XQ; Zhao XC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):86-9. PubMed ID: 12648401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of ultrasound tomography in the diagnosis and follow-up of fatty liver].
    Lössner C; Cuno S; Kleine S; Kleine FD
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):22-6. PubMed ID: 3286217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between intrasinusoidal neutrophilic infiltration and ceroid-lipofuscinosis in alcoholic liver fibrosis with or without fatty change: clinicopathological comparison with nutritional fatty liver.
    Kishi M; Maeyama S; Koike J; Aida Y; Yoshida H; Uchikoshi T
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):366A-370A. PubMed ID: 8986240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathogenesis, clinical aspects and development of fatty liver].
    Eitel B; Kleine FD; Kleine S
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(3):111-6. PubMed ID: 4042954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B; Marchioni GF; Capitolo S
    Minerva Med; 1974 Aug; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract]   [Full Text] [Related]  

  • 26. [Glutathione in the treatment of chronic fatty liver diseases].
    Dentico P; Volpe A; Buongiorno R; Grattagliano I; Altomare E; Tantimonaco G; Scotto G; Sacco R; Schiraldi O
    Recenti Prog Med; 1995; 86(7-8):290-3. PubMed ID: 7569285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biopsy study of chronic alcoholic hepatopathies. Assessment of the steatosis in the course of arginine thiazolidinecarboxylate treatment].
    Mauro G; Vigiani L
    Clin Ter; 1982 Feb; 100(4):359-74. PubMed ID: 7083785
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunohistochemical studies on the occurrence of HBs antigen in alcoholic fatty liver and alcoholic fatty liver hepatitis].
    Thaler H; Beham A
    Wien Klin Wochenschr; 1986 Mar; 98(5):151-5. PubMed ID: 3515768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis.
    Gluud C; Christoffersen P; Eriksen J; Wantzin P; Knudsen BB
    Am J Gastroenterol; 1987 Jul; 82(7):660-4. PubMed ID: 3300274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
    Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
    [No Abstract]   [Full Text] [Related]  

  • 31. [A new pharmacological association in therapy of dyslipidemic and arteriosclerotic syndromes].
    Cucinotta D
    Minerva Med; 1972 Feb; 63(15):870-85. PubMed ID: 4259330
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influences of jiejiu gankang granule on lipid metabolism and liver function of alcohol-fatty-liver about mice].
    Li B; Wang L; Sun R
    Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):2048-50. PubMed ID: 19086652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.
    Orrego H; Kalant H; Israel Y; Blake J; Medline A; Rankin JG; Armstrong A; Kapur B
    Gastroenterology; 1979 Jan; 76(1):105-15. PubMed ID: 758131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of cholineorotate on experimental fatty liver in the rat].
    Petzold H; Storch H; Hohlfeld R
    Z Gesamte Inn Med; 1970 Aug; 25(15):697-700. PubMed ID: 4269665
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinicopathological study of alcoholic fibrosis.
    Takada A; Nei J; Matsuda Y; Kanayama R
    Am J Gastroenterol; 1982 Sep; 77(9):660-6. PubMed ID: 7114030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis].
    Váli L; Blázovics A; Fehér J
    Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of polyene antibiotics on the development of alcoholic-dietary fatty degeneration of the liver in rats].
    Titov AV; Tarasova OV; Slobodskaia VV; Vavilin GI
    Antibiotiki; 1982 Dec; 27(12):42-6. PubMed ID: 7165293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
    Niemelä O; Risteli L; Sotaniemi EA; Risteli J
    Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.